Subtype
Female Reproductive System Neoplasm
CI-CAN-00000885Explore in graph →
Non-malignant1,629 active trials11 approved drugs139 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00000885Explore in graph →
Clinical trials
7,170 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03787056 | Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients(ONCOPRO) | recruiting | N/A | 410 | Hospices Civils de LyonOTHER | 1 | Jul 16, 2021 | clinicaltrials |
| NCT04834544 | A Study of Maintenance DCVAC/OvCa After First-line Chemotherapy Added Standard of Care | recruiting | Phase 2 | 75 | Peking University Third HospitalOTHER | 1 | May 3, 2021 |
| NCT04783805 | Conservative Management of HSIL in Patients With Future Pregnancy Aspiration | recruiting | — | 200 | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauOTHER | 1 | Mar 5, 2021 | clinicaltrials |
| NCT03025477 | Two Therapeutic Strategies in First-line in Patients With Epithelial Advanced Ovarian Cancer(CHIMOVIP) | recruiting | Phase 2 | 84 | Groupe Hospitalier Diaconesses Croix Saint-SimonOTHER | 1 | Feb 11, 2021 | clinicaltrials |
| NCT04733820 | Clinical Efficacy of Adjuvant Chemotherapy in Patients With Locally Advanced Cervical Cancer Who Did Not Meet the NCCN Guidelines for Adjuvant Treatment After NACT Combined With Surgery | recruiting | Phase 3 | 340 | Huazhong University of Science and TechnologyOTHER | 1 | Feb 2, 2021 | clinicaltrials |
| NCT04714957 | PITCHER (Peritoneal Carcinomatosis Heterogeneity) | recruiting | — | 20 | Hospices Civils de LyonOTHER | 1 | Jan 20, 2021 | clinicaltrials |
| NCT04710797 | Lymphadenectomy in Early Ovarian Cancer(LOVE) | recruiting | N/A | 656 | Sun Yat-sen UniversityOTHER | 1 | Jan 15, 2021 | clinicaltrials |
| NCT03667417 | Genetic Predisposition to Breast and Ovarian Cancer: Prospective Study of BRCAx Gene Mutation(GENEPSO) | recruiting | — | 5,000 | Institut Paoli-CalmettesOTHER | 1 | Jul 1, 2020 | clinicaltrials |
| NCT04453904 | Modality of Adjuvant Radiotherapy and Chemotherapy for Stage Ⅲ Endometrial Cancer | recruiting | N/A | 654 | Peking University People's HospitalOTHER | 1 | Jul 1, 2020 | clinicaltrials |
| NCT04063527 | Phase III Trial of Stage I Ovarian Cancer After Surgery | recruiting | Phase 3 | 360 | Japanese Gynecologic Oncology GroupOTHER | 2 | Aug 30, 2019 | clinicaltrials |
| NCT02803970 | KOrean Borderline Ovarian Tumor (KOBOT) Registry(KOBOT) | recruiting | — | 3,000 | Kangbuk Samsung HospitalOTHER | 1 | Apr 3, 2019 | clinicaltrials |
| NCT03249519 | Radiation Therapy or Chemoradiation, Interstitial Brachytherapy in Combination With Hyperthermia in Advanced Cervical Cancer | recruiting | N/A | 999 | University of Erlangen-Nürnberg Medical SchoolOTHER | 1 | Aug 15, 2017 | clinicaltrials |
| NCT01000259 | Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovarian Epithelial Cancer | recruiting | — | 174 | Gynecologic Oncology GroupNETWORK | 1 | May 5, 2017 | clinicaltrials |
| NCT02543710 | Biomarker Guided Treatment in Gynaecological Cancer(Momatec2) | recruiting | Phase 4 | 1,300 | Haukeland University HospitalOTHER | 3 | Mar 28, 2017 | clinicaltrials |
| NCT02892877 | The French National Reference Centre of GTD(French GTDC) | recruiting | — | 25,500 | Hospices Civils de LyonOTHER | 1 | Sep 8, 2016 | clinicaltrials |
| NCT02869490 | Institut Paoli Calmettes Cervical Cancer Database | recruiting | — | 6,000 | Institut Paoli-CalmettesOTHER | 1 | Aug 17, 2016 | clinicaltrials |
| NCT02869568 | Institut Paoli Calmettes Ovarian Cancer Database | recruiting | — | 6,000 | Institut Paoli-CalmettesOTHER | 1 | Aug 17, 2016 | clinicaltrials |
Data updated 22 days agoSource updated Jul 16, 2021source: clinicaltrials